Genomic features of host adaptation of Campylobacter in low-income settings
低收入环境中弯曲杆菌宿主适应的基因组特征
基本信息
- 批准号:10615827
- 负责人:
- 金额:$ 17.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAcuteAffectAnimal FeedAnimal HusbandryAntibioticsAreaBioinformaticsBiologyBirdsBirthCampylobacterCampylobacter infectionCampylobacter jejuniChildChronicClinicalClinical ManagementCohort StudiesCollaborationsCollectionCommunicable DiseasesDataData SetDatabasesDiagnosticDiseaseDisease OutbreaksDomestic FowlsEnteralEpidemiologistEpidemiologyEventFamilyFocal InfectionFood ProcessingGastroenteritisGeneral PractitionersGeneticGenomeGenomicsGoalsGuillain Barré SyndromeHouseholdHumanHygieneImmunocompromised HostIndividualInfectionInterventionInvestigationInvestmentsKnowledgeLocalized DiseaseLongitudinal cohort studyLow incomeMeasuresMetabolicMethodsMicrobeMissionModelingOrganismOutcomePediatric cohortPeruvianPhenotypePopulationPositioning AttributeProductivityPublic HealthResearchResearch PersonnelRiskRuminantsSalmonella entericaSanitationSeriesSourceSpecialistTestingUnited States National Institutes of HealthVaccinesVeterinariansWaterZoonosesantimicrobialchronic infectioncohortdesigndisorder controlenteritisfollow-upfuture outbreakgenome analysisgenome sequencinggenome wide association studyhuman diseasehuman pathogenimprovedinnovationmicrobialmodel organismpathogenpreventspatiotemporalstool sampletransmission processwhole genome
项目摘要
ABSTRACT
There is strong epidemiologic evidence of human adaption of the zoonotic pathogen Campylobacter. However,
the genomic features of such adaptation have not been systematically evaluated. The overall objective of this
project is to identify specific genomic features of Campylobacter that are associated with adaptation to the
human host with the long-term goal of applying this knowledge to global reference databases to inform host
attribution and guide improved disease control measures to reduce the global burden of Campylobacter
disease in humans. Our central hypothesis is that in highly endemic settings, long-term exposure has allowed
adaptation to the human host, as opposed to the transient infection epidemiology we usually observe with
Campylobacter. Previous evidence of human adaption has been previously suggested by prolonged carriage in
immunosuppressed patients and that certain Campylobacter lineages associated with human disease and
chronic sequelae such as GBS, are rarely found outside the human host. We have identified these
observations in two longitudinal cohort studies in the Peruvian Amazon that cumulatively comprise over 1400
child-years of surveillance, 20,000 stool samples and 850 Campylobacter isolates. Specifically, we evidence a)
persistent Campylobacter infection and carriage in over 70% of children with complete 0 to 24-month follow-up,
b) high-level of C. jejuni strain diversity derived from humans compared to the global collection of clinical
genomes, c) high proportion of strains described exclusively in human hosts (such ST-403, ST2802 and ST-
2993), as compared to the global reference collection and d) considerable reduced genome size of human
derived C. jejuni genomes compared to the global reference collection. In order to test our hypothesis, we will
1) Identify genomic features of persistent Campylobacter infections in humans, and 2) Determine if
spatiotemporally clustered infections represent human to human transmission. The proposed project will unite
a highly complementary group of accomplished researchers with expertise in epidemiology, evolutionary
biology, Campylobacter genomics, and bioinformatics to inform strategic and targeted disease control
interventions for Campylobacter control in an area with one of the highest documented rates of human MDR
Campylobacter infection. [The project is innovative in the way it applies microbial GWAS methods to capitalize
on an exceptional strain bank derived from well-defined longitudinal cohort studies to efficiently identify host
adaptation.] [High quality evidence of human host adaptation generated by this study would be paradigm
shifting to strategies used to control Campylobacter and would likely to alter the clinical management of
Campylobacter enteritis.]
摘要
有强有力的流行病学证据表明,人类适应了人畜共患病原体弯曲杆菌。然而,在这方面,
这种适应的基因组特征尚未得到系统的评价。本报告的总体目标
该项目的目的是确定弯曲杆菌的特定基因组特征,这些特征与适应环境有关。
人类宿主的长期目标是将这些知识应用于全球参考数据库,
归因和指导改进疾病控制措施,以减少全球弯曲杆菌负担
人类的疾病。我们的中心假设是,在高度流行的环境中,长期暴露使
适应人类宿主,而不是我们通常观察到的短暂感染流行病学,
弯曲杆菌先前人类适应的证据曾通过人类长期携带而提出。
免疫抑制患者和某些与人类疾病相关的弯曲杆菌谱系,
慢性后遗症,如GBS,在人类宿主之外很少发现。我们已经确定了这些
在秘鲁亚马逊地区进行的两项纵向队列研究中,
儿童年监测,20,000粪便样本和850弯曲杆菌分离。具体而言,我们证明a)
持续性弯曲杆菌感染和携带超过70%的儿童完成0至24个月的随访,
B)C.与全球临床收集相比,来自人类的空肠菌株多样性
基因组,c)仅在人类宿主中描述的菌株比例很高(例如ST-403、ST 2802和ST-
2993),与全球参考集合相比,以及d)人类的基因组大小显著减小
衍生C。空肠基因组与全球参考数据库进行比较。为了验证我们的假设,我们将
1)确定人类持续性弯曲杆菌感染的基因组特征,以及2)确定
时空聚集性感染代表人传人。该项目将联合
一群在流行病学、进化论和生物学方面具有专业知识的有成就的研究人员,
生物学、弯曲杆菌基因组学和生物信息学,为战略性和针对性疾病控制提供信息
在人类MDR记录率最高的地区之一进行弯曲杆菌控制干预
弯曲杆菌感染。[The该项目是创新的方式,它应用微生物GWAS方法,以资本化
在从明确的纵向队列研究中获得的特殊菌株库上,
适应。] [High这项研究产生的人类宿主适应性的质量证据将是范例
转向用于控制弯曲杆菌的策略,可能会改变临床管理,
弯曲杆菌肠炎。]
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret N Kosek其他文献
Epidemiology of emShigella/em species and serotypes in children: a retrospective substudy of the MAL-ED observational birth cohort study
儿童中志贺氏菌属物种和血清型的流行病学:MAL-ED 观察性出生队列研究的回顾性亚研究
- DOI:
10.1016/j.lanmic.2024.101064 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:20.400
- 作者:
Elizabeth T Rogawski McQuade;Jie Liu;Mustafa Mahfuz;Alexandre Havt;Tintu Varghese;Jasmin Shrestha;Furqan Kabir;Pablo Peñataro Yori;Amidou Samie;Queen Saidi;Adil Kalam;Fatima Aziz;Sahrish Muneer;Rashidul Haque;Aldo A M Lima;Maheswari Kalaivanan;Sanjaya Shrestha;Najeeha Talat Iqbal;Zulfiqar Bhutta;Margaret N Kosek;Eric R Houpt - 通讯作者:
Eric R Houpt
Spatiotemporal variation in risk of emShigella/em infection in childhood: a global risk mapping and prediction model using individual participant data
儿童时期志贺氏菌感染风险的时空变化:使用个体参与者数据的全球风险绘图和预测模型
- DOI:
10.1016/s2214-109x(22)00549-6 - 发表时间:
2023-03-01 - 期刊:
- 影响因子:18.000
- 作者:
Hamada S Badr;Josh M Colston;Nhat-Lan H Nguyen;Yen Ting Chen;Eleanor Burnett;Syed Asad Ali;Ajit Rayamajhi;Syed M Satter;Nguyen Van Trang;Daniel Eibach;Ralf Krumkamp;Jürgen May;Ayola Akim Adegnika;Gédéon Prince Manouana;Peter Gottfried Kremsner;Roma Chilengi;Luiza Hatyoka;Amanda K Debes;Jerome Ateudjieu;Abu S G Faruque;Margaret N Kosek - 通讯作者:
Margaret N Kosek
A cross-sectional study of associations between the sup13/supC-sucrose breath test, the lactulose rhamnose assay, and growth in children at high risk of environmental enteropathy
一项关于¹³C - 蔗糖呼气试验、乳果糖鼠李糖检测与环境性肠病高风险儿童生长发育之间关联的横断面研究
- DOI:
10.1016/j.ajcnut.2024.10.001 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:6.900
- 作者:
Nirupama Shivakumar;Sayeeda Huq;Maribel Paredes-Olortegui;Silvenus Ochieng Konyole;Sarita Devi;Roger Yazbeck;Victor O Owino;Andrew F Brouwer;Margaret N Kosek;Paul Kelly;Douglas J Morrison;Gwenyth O Lee - 通讯作者:
Gwenyth O Lee
Margaret N Kosek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret N Kosek', 18)}}的其他基金
Capacity building in climate and health in the Peruvian Amazon
秘鲁亚马逊地区气候和健康方面的能力建设
- 批准号:
10838170 - 财政年份:2023
- 资助金额:
$ 17.95万 - 项目类别:
Genomic features of host adaptation of Campylobacter in low-income settings
低收入环境中弯曲杆菌宿主适应的基因组特征
- 批准号:
10452900 - 财政年份:2022
- 资助金额:
$ 17.95万 - 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
- 批准号:
10371146 - 财政年份:2021
- 资助金额:
$ 17.95万 - 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
- 批准号:
10600981 - 财政年份:2021
- 资助金额:
$ 17.95万 - 项目类别:
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
弯曲杆菌的基因组流行病学可改善中低收入国家的疾病控制
- 批准号:
10184256 - 财政年份:2021
- 资助金额:
$ 17.95万 - 项目类别:
RFA-GH-20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
RFA-GH-20-005,在秘鲁进行综合传染病和公共卫生研究
- 批准号:
10842492 - 财政年份:2020
- 资助金额:
$ 17.95万 - 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
- 批准号:
10259643 - 财政年份:2020
- 资助金额:
$ 17.95万 - 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
- 批准号:
10425210 - 财政年份:2020
- 资助金额:
$ 17.95万 - 项目类别:
GH20-005, Conducting Integrated Infectious Disease and Public Health Research in Peru
GH20-005,在秘鲁进行综合传染病和公共卫生研究
- 批准号:
10462449 - 财政年份:2020
- 资助金额:
$ 17.95万 - 项目类别:
Enabling Infectious Disease Research Capacity in the Peruvian Amazon
增强秘鲁亚马逊地区的传染病研究能力
- 批准号:
10456387 - 财政年份:2018
- 资助金额:
$ 17.95万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 17.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 17.95万 - 项目类别:
Operating Grants